| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911425 | Lung Cancer | 2011 | 8 Pages |
Abstract
High expression of cyclin D3 confers resistance to erlotinib in vitro and in vivo. Cyclin D3 immunohistochemical staining warrants investigation as a biomarker for predicting erlotinib resistance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
W. Jeffrey Petty, William R. Voelzke, James J. Urbanic, Victor A. Varela, Lynsay L. Waller, Catherine B. Swift, R. Matthew Graham, Vincent A. Memoli, Konstantin H. Dragnev,